Publication | Open Access

Genetically modified CD7-targeting allogeneic CAR-T cell therapy with enhanced efficacy for relapsed/refractory CD7-positive hematological malignancies: a phase I clinical study

Cell TherapyMedicineImmunologyHematologyEnhanced EfficacyAutoimmunityAdult T-cell Leukemia-lymphomaRadiation OncologyImmunotherapyCell TransplantationHealth Sciences